BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 36907973)

  • 1. Beyond diagnosis: is there a role for radiomics in prostate cancer management?
    Stanzione A; Ponsiglione A; Alessandrino F; Brembilla G; Imbriaco M
    Eur Radiol Exp; 2023 Mar; 7(1):13. PubMed ID: 36907973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of radiomics on prostate cancer detection: a systematic review of clinical applications.
    Sugano D; Sanford D; Abreu A; Duddalwar V; Gill I; Cacciamani GE
    Curr Opin Urol; 2020 Nov; 30(6):754-781. PubMed ID: 32941257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MRI-derived radiomics models for diagnosis, aggressiveness, and prognosis evaluation in prostate cancer.
    Zhu X; Shao L; Liu Z; Liu Z; He J; Liu J; Ping H; Lu J
    J Zhejiang Univ Sci B; 2023 Aug; 24(8):663-681. PubMed ID: 37551554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent.
    Mottet N; Bellmunt J; Bolla M; Briers E; Cumberbatch MG; De Santis M; Fossati N; Gross T; Henry AM; Joniau S; Lam TB; Mason MD; Matveev VB; Moldovan PC; van den Bergh RCN; Van den Broeck T; van der Poel HG; van der Kwast TH; Rouvière O; Schoots IG; Wiegel T; Cornford P
    Eur Urol; 2017 Apr; 71(4):618-629. PubMed ID: 27568654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiomics and artificial intelligence in prostate cancer: new tools for molecular hybrid imaging and theragnostics.
    Liberini V; Laudicella R; Balma M; Nicolotti DG; Buschiazzo A; Grimaldi S; Lorenzon L; Bianchi A; Peano S; Bartolotta TV; Farsad M; Baldari S; Burger IA; Huellner MW; Papaleo A; Deandreis D
    Eur Radiol Exp; 2022 Jun; 6(1):27. PubMed ID: 35701671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time series radiomics for the prediction of prostate cancer progression in patients on active surveillance.
    Sushentsev N; Rundo L; Abrego L; Li Z; Nazarenko T; Warren AY; Gnanapragasam VJ; Sala E; Zaikin A; Barrett T; Blyuss O
    Eur Radiol; 2023 Jun; 33(6):3792-3800. PubMed ID: 36749370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative prediction of pelvic lymph nodes metastasis in prostate cancer using an ADC-based radiomics model: comparison with clinical nomograms and PI-RADS assessment.
    Liu X; Wang X; Zhang Y; Sun Z; Zhang X; Wang X
    Abdom Radiol (NY); 2022 Sep; 47(9):3327-3337. PubMed ID: 35763053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the Use of Artificial Intelligence in the Management of Prostate Cancer.
    Chu TN; Wong EY; Ma R; Yang CH; Dalieh IS; Hung AJ
    Curr Urol Rep; 2023 May; 24(5):231-240. PubMed ID: 36808595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiomics Models Based on Apparent Diffusion Coefficient Maps for the Prediction of High-Grade Prostate Cancer at Radical Prostatectomy: Comparison With Preoperative Biopsy.
    Han C; Ma S; Liu X; Liu Y; Li C; Zhang Y; Zhang X; Wang X
    J Magn Reson Imaging; 2021 Dec; 54(6):1892-1901. PubMed ID: 33682286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate Cancer Radiogenomics-From Imaging to Molecular Characterization.
    Ferro M; de Cobelli O; Vartolomei MD; Lucarelli G; Crocetto F; Barone B; Sciarra A; Del Giudice F; Muto M; Maggi M; Carrieri G; Busetto GM; Falagario U; Terracciano D; Cormio L; Musi G; Tataru OS
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What benefit can be obtained from magnetic resonance imaging diagnosis with artificial intelligence in prostate cancer compared with clinical assessments?
    Zhao LT; Liu ZY; Xie WF; Shao LZ; Lu J; Tian J; Liu JG
    Mil Med Res; 2023 Jun; 10(1):29. PubMed ID: 37357263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Radiomics nomogram for predicting bone metastasis in newly diagnosed prostate cancer patients.
    Zhang W; Mao N; Wang Y; Xie H; Duan S; Zhang X; Wang B
    Eur J Radiol; 2020 Jul; 128():109020. PubMed ID: 32371181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiomics analysis of 18F-Choline PET/CT in the prediction of disease outcome in high-risk prostate cancer: an explorative study on machine learning feature classification in 94 patients.
    Alongi P; Stefano A; Comelli A; Laudicella R; Scalisi S; Arnone G; Barone S; Spada M; Purpura P; Bartolotta TV; Midiri M; Lagalla R; Russo G
    Eur Radiol; 2021 Jul; 31(7):4595-4605. PubMed ID: 33443602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Evidence for Using Artificial Intelligence to Enhance Prostate Cancer MR Imaging.
    Canellas R; Kohli MD; Westphalen AC
    Curr Oncol Rep; 2023 Apr; 25(4):243-250. PubMed ID: 36749494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Automated multiparametric localization of prostate cancer based on B-mode, shear-wave elastography, and contrast-enhanced ultrasound radiomics.
    Wildeboer RR; Mannaerts CK; van Sloun RJG; Budäus L; Tilki D; Wijkstra H; Salomon G; Mischi M
    Eur Radiol; 2020 Feb; 30(2):806-815. PubMed ID: 31602512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRI-Based Radiomics Signature for the Preoperative Prediction of Extracapsular Extension of Prostate Cancer.
    Ma S; Xie H; Wang H; Han C; Yang J; Lin Z; Li Y; He Q; Wang R; Cui Y; Zhang X; Wang X
    J Magn Reson Imaging; 2019 Dec; 50(6):1914-1925. PubMed ID: 31062459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiparametric MRI and auto-fixed volume of interest-based radiomics signature for clinically significant peripheral zone prostate cancer.
    Bleker J; Kwee TC; Dierckx RAJO; de Jong IJ; Huisman H; Yakar D
    Eur Radiol; 2020 Mar; 30(3):1313-1324. PubMed ID: 31776744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiomics Based on MRI as a Biomarker to Guide Therapy by Predicting Upgrading of Prostate Cancer From Biopsy to Radical Prostatectomy.
    Zhang GM; Han YQ; Wei JW; Qi YF; Gu DS; Lei J; Yan WG; Xiao Y; Xue HD; Feng F; Sun H; Jin ZY; Tian J
    J Magn Reson Imaging; 2020 Oct; 52(4):1239-1248. PubMed ID: 32181985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of machine learning algorithms to predict clinically significant prostate cancer of the peripheral zone with multiparametric MRI using clinical assessment categories and radiomic features.
    Bernatz S; Ackermann J; Mandel P; Kaltenbach B; Zhdanovich Y; Harter PN; Döring C; Hammerstingl R; Bodelle B; Smith K; Bucher A; Albrecht M; Rosbach N; Basten L; Yel I; Wenzel M; Bankov K; Koch I; Chun FK; Köllermann J; Wild PJ; Vogl TJ
    Eur Radiol; 2020 Dec; 30(12):6757-6769. PubMed ID: 32676784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Novel Green Learning Artificial Intelligence for Prostate Cancer Imaging: A Balanced Alternative to Deep Learning and Radiomics.
    Kaneko M; Magoulianitis V; Ramacciotti LS; Raman A; Paralkar D; Chen A; Chu TN; Yang Y; Xue J; Yang J; Liu J; Jadvar DS; Gill K; Cacciamani GE; Nikias CL; Duddalwar V; Jay Kuo CC; Gill IS; Abreu AL
    Urol Clin North Am; 2024 Feb; 51(1):1-13. PubMed ID: 37945095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.